Ista Pharmaceuticals, Inc. (ISTA) Misses Q3 EPS by 2c; Guides FY11
Tweet
Share
E-mailGet Alerts ISTA Hot Sheet
Price: $9.09 --0%
Financial Fact:
Gain on derivative valuation: -1.75M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Gain on derivative valuation: -1.75M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Ista Pharmaceuticals, Inc. (NASDAQ: ISTA) reported Q3 EPS of $0.09, $0.02 worse than the analyst estimate of $0.11. Revenue for the quarter came in at $41.4 million versus the consensus estimate of $43.34 million.
Ista Pharmaceuticals, Inc. sees FY2011 EPS of at least $0.10, versus the consensus of $0.18. Ista Pharmaceuticals, Inc. sees FY2011 revenue of $160-$175 million, versus the consensus of $168.5 million.
Ista Pharmaceuticals, Inc. sees FY2011 EPS of at least $0.10, versus the consensus of $0.18. Ista Pharmaceuticals, Inc. sees FY2011 revenue of $160-$175 million, versus the consensus of $168.5 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ondas Holdings Inc. (ONDS) Misses Q2 EPS by 9c
- Forum Markets, Incorporated (FRMM) Tops Q2 EPS by 29c ; Offers Guidance
- Stratasys (SSYS) Tops Q2 EPS by 2c ;; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
